Kinaxis has this morning announced that MorphoSys has been welcomes into its community of supply chain innovators. The fast-growing US and European biotech company joins an expanding list of businesses that have gone live with advanced planning in less than 12 weeks as a result of RapidStart, Kinaxis’s enterprise deployment methodology.
Last year, MorphoSys received accelerated US approval for its first oncology medicine, a combination treatment for a certain type of blood cancer. With a new product, MorphoSys has many moving elements when planning supply and demand. It had been running what-if scenarios in Excel which was time consuming, error prone and not sustainable.
MorphoSys selected Kinaxis for demand planning, supply planning and inventory management to better synchronise supply and demand for its newly introduced cancer therapy. Leveraging the Kinaxis RapidResponse platform and concurrent planning, MorphoSys gained agility and transparency across its supply chain to drive smarter, more timely decision making. The first phase of the MorphoSys deployment was completed in just eight weeks leveraging the RapidStart accelerated go-live process.
“By spending so much time focusing on the accuracy of the data, we were losing sight of the information that the data was telling us,” suggested Ann Merchant, Head of Global Supply Chain, MorphoSys. “At the same time, as we were introducing a new product and developing our process, we knew we needed a tool that would allow us to manage complexity and provide the agility to make changes instantly. Kinaxis demonstrated a clear understanding of our business, and willingness to be flexible, and a solution that sees us realising benefits in a matter of weeks.”
With Kinaxis, MorphoSys can run what-if scenarios to instantly see what the impact of changes to its supply and demand will be when unavoidable adjustments to the plan occur. In the future, MorphoSys will focus on inventory optimisation and monitor inventory levels more quickly. The company also plans to integrate the available output with other internal departments like finance to better align financial planning.
